Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.49
-0.05 (-1.41%)
At close: Aug 18, 2025, 1:14 PM
Sonnet BioTherapeutics Revenue
Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending June 30, 2025, Sonnet BioTherapeutics generated $0 in revenue.
Revenue (ttm)
18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
1.43K
Employees
13
Market Cap
21.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Sep 30, 2024 | 18.63K | -87.40% |
| Sep 30, 2023 | 147.81K | -57.76% |
| Sep 30, 2022 | 349.94K | -27.64% |
| Sep 30, 2021 | 483.63K | +Infinity% |
| Sep 30, 2020 | 0 | -100.00% |
| Sep 30, 2019 | 40.61M | +32.15% |
| Dec 31, 2018 | 30.73M | -25.82% |
| Dec 31, 2017 | 41.43M | -0.65% |
| Dec 31, 2016 | 41.7M | -1.64% |
| Dec 31, 2015 | 42.4M | +Infinity% |
| Dec 31, 2014 | 0 | -100.00% |
| Dec 31, 2013 | 17.5M | +154.20% |
| Dec 31, 2012 | 6.88M | +370.21% |
| Dec 31, 2011 | 1.46M | +973.96% |
| Dec 31, 2010 | 136.3K | -80.09% |
| Dec 31, 2009 | 684.67K | +192.53% |
| Dec 31, 2008 | 234.06K | n/a |